BPC-157 + KPV Blend

A research blend co-dosing BPC-157 (a 15-amino-acid body protection compound derived from gastric juice, investigated for gastrointestinal and soft-tissue repair) with KPV (a C-terminal alpha-MSH tripeptide with NF-kB-mediated anti-inflammatory activity). The pairing is studied in preclinical models for gut-lining repair, colitis, and broader inflammation-driven tissue damage, combining BPC-157's angiogenic and reparative effects with KPV's cytokine-modulating profile. Neither component is FDA-approved for human therapeutic use.